Hu Li

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Higher risk of postpartum phase transition to immune-active among HBeAg-positive pregnant women with indeterminate phase.

Higher risk of postpartum phase transition to immune-active among HBeAg-positive pregnant women with indeterminate phase.

Journal: Frontiers in cellular and infection microbiology

Published: June 24, 2025

PgRNA closely correlates to cytokine profile in HBeAg-positive pregnant women undergoing prophylactic antiviral intervention.

PgRNA closely correlates to cytokine profile in HBeAg-positive pregnant women undergoing prophylactic antiviral intervention.

Journal: Frontiers in immunology

Published: October 15, 2024

Profiles of HBcrAg and pgRNA in Pregnant Women With Chronic HBV Under Different Disease Phases and Antiviral Prophylaxis.

Profiles of HBcrAg and pgRNA in Pregnant Women With Chronic HBV Under Different Disease Phases and Antiviral Prophylaxis.

Journal: Open forum infectious diseases

Published: September 28, 2023

PgRNA kinetics predict HBsAg reduction in pregnant chronic hepatitis B carriers after treatment cessation.

PgRNA kinetics predict HBsAg reduction in pregnant chronic hepatitis B carriers after treatment cessation.

Journal: Frontiers in cellular and infection microbiology

Published: September 28, 2022

A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in China.

A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in China.

Journal: Antiviral research

Published: March 12, 2021

Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg.

Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg.

Journal: International immunopharmacology

Published: April 05, 2018

Circulating PD-1hiCXCR5+CD4+ T cells are associated with a decrease in hepatitis B surface antigen levels in patients with chronic hepatitis B who are receiving peginterferon-α therapy.

Circulating PD-1hiCXCR5+CD4+ T cells are associated with a decrease in hepatitis B surface antigen levels in patients with chronic hepatitis B who are receiving peginterferon-α therapy.

Journal: Molecular immunology

Published: April 01, 2018

Upgrade Combination Response Is Limited by Prolonged Nucelos(t)ide Analogue Therapy in HBeAg-positive Chronic Hepatitis B: A Real-life Study.

Upgrade Combination Response Is Limited by Prolonged Nucelos(t)ide Analogue Therapy in HBeAg-positive Chronic Hepatitis B: A Real-life Study.

Journal: Journal of clinical and translational hepatology

Published: March 10, 2017

Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-α therapy.

Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-α therapy.

Journal: Molecular immunology

Published: December 30, 2015

Efficacy of PEGylated Interferon in Treatment-Experienced Chinese Patients With HBeAg Positive Chronic Hepatitis B.

Efficacy of PEGylated Interferon in Treatment-Experienced Chinese Patients With HBeAg Positive Chronic Hepatitis B.

Journal: Hepatitis monthly

Published: December 09, 2015

A strong conservative tendency in HBV transcriptase (RT): a majority of natural RT mutations derived from the S gene.

A strong conservative tendency in HBV transcriptase (RT): a majority of natural RT mutations derived from the S gene.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: May 22, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026